Regulatory Affairs

Institutional Biosafety Committee

The St. Vincent Institutional Biosafety Committee (IBC) reviews all study protocols that involve the use of recombinant DNA and gene therapy. The IBC operates under the guidance of the Office of Biotechnology Activities of the National Institutes of Health. For additional information please contact the Research & Regulatory Affairs Department at (317) 338-2194.

• Guidelines for Research Involving Recombinant DNA Molecules
• Bloodborne Pathogens
• Biosafety in Microbiological and Biomedical Laboratories
• Biological Defense Safety Program